Data › Companies › ECVT

Ecovyst Inc. (ECVT)

NYSE · Chemicals & Allied Products · Manufacturing · CIK 1708035 · fiscal year ends in Dec

Closing price $10.23 on 29 Oct 2026; 52-week range $7.84 to $14.97.

Key figures

The last twelve months reported, with the latest price and balance sheet.

Revenue, last twelve months
$869.3M
Revenue growth
39.8%
Net income, last twelve months
-$61.3M
Earnings per share
-$0.53
Gross margin
21.3%
Operating margin
9.4%
Net margin
-7.1%
Return on equity
-10.4%
Market value
$1.1B
Cash
$87.8M
Debt
$493.0M
Debt to equity
0.84
Shares outstanding
109.5M

Financial statements

Revenue, profit and cash flow by fiscal year, each year linked to its annual report.

Fiscal yearYear endRevenueOperating incomeNet incomeEPSFree cash flowFiling
FY202531 Dec 2025$723.5M$64.9M-$71.1M-$0.61$69.9M10-K filed 27 Feb 2026
FY202431 Dec 2024$598.3M$85.1M-$6.7M-$0.06$94.3M10-K filed 28 Feb 2025
FY202331 Dec 2023$584.8M$89.6M$71.2M$0.60$78.6M10-K filed 29 Feb 2024
FY202231 Dec 2022$820.2M$104.4M$73.7M$0.55$127.7M10-K filed 28 Feb 2023
FY202131 Dec 2021$611.2M$54.6M-$139.9M-$1.02$69.9M10-K filed 1 Mar 2022

By quarter

QuarterQuarter endRevenueNet incomeEPS
Q2 FY202630 Jun 2026$250.0M$7.9M$0.07
Q1 FY202631 Mar 2026$215.0M$4.3M$0.04
Q4 FY202531 Dec 2025$199.4M$5.7M$0.05
Q3 FY202530 Sep 2025$204.9M-$79.3M-$0.69
Q2 FY202530 Jun 2025$176.1M$6.0M$0.05
Q1 FY202531 Mar 2025$143.1M-$3.6M-$0.03
Q4 FY202431 Dec 2024$148.9M-$30.4M-$0.26
Q3 FY202430 Sep 2024$153.9M$14.3M$0.12

Revenue by segment

As the company reports it in the segment note of its annual report.

By product, FY2025

SegmentRevenueShare
Regeneration and treatment services$361.2M49.9%
Industrial, mining & automotive$327.9M45.3%
Other$34.3M4.7%

Company events

The newest 8-K filings of 114 held.

FiledFormEventItems
28 Oct 20268-KLeadership change5.02, 9.01
24 Aug 20268-KLeadership change, Investor update5.02, 7.01, 9.01
5 Aug 20268-KResults2.02, 9.01
30 Jun 20268-KMaterial agreement, New debt, Other events1.01, 2.03, 8.01, 9.01
21 May 20268-KShareholder vote5.07
5 May 20268-KResults2.02, 9.01
4 May 20268-KMaterial agreement1.01, 9.01
26 Feb 20268-KResults2.02, 9.01
7 Jan 20268-KDeal completed, Leadership change, Debt accelerated2.01, 2.04, 5.02, 9.01
12 Dec 20258-KLeadership change5.02
4 Nov 20258-KResults2.02, 9.01
11 Sep 20258-KMaterial agreement1.01, 9.01

Every filing

The newest filings with the SEC of 210 held.

FiledFormPeriod
28 Oct 20268-K22 Oct 2026
24 Aug 20268-K21 Aug 2026
6 Aug 202610-Q30 Jun 2026
5 Aug 20268-K5 Aug 2026
30 Jun 20268-K30 Jun 2026
22 Jun 202611-K31 Dec 2025
21 May 20268-K20 May 2026
5 May 202610-Q31 Mar 2026
5 May 20268-K5 May 2026
4 May 20268-K1 May 2026
15 Apr 2026ARS31 Dec 2025
15 Apr 2026DEF 14A20 May 2026

Insider trades

Form 4 trades by officers, directors and 10% owners, last 12 months.

TradedInsiderTypeSharesPriceValueHeld afterForm 4
10 Sep 2026Humble Patti A., DirectorPurchase24,875$10.05$250.0K33,97414 Sep 2026
2 Jun 2026Lorance Sarah, DirectorSale outside a trading plan8,450$13.33$112.6K54,7003 Jun 2026
7 Nov 2025Ward Susan F, DirectorSale outside a trading plan15,000$8.40$126.0K78,26110 Nov 2025

Planned insider sales

Form 144 notices, filed when the sell order goes to the broker.

FiledSellerSharesValuePlanned sale
17 Jul 2026Susan Ward, Director29,886$385.5K17 Jul 2026
2 Jun 2026SARAH J LORANCE, Director8,450$112.6K2 Jun 2026
7 Nov 2025Susan Ward, Director15,000$126.0K7 Nov 2025

Large holders

Schedule 13D and 13G filings by holders of more than 5% of the voting shares.

FiledHolderScheduleStakeShares
31 Jul 2026Vanguard Portfolio Management13G5.65%6.2M
14 Jul 2026Dimensional Fund Advisors LP13G amended6%6.6M
8 May 2026Hotchkis and Wiley Capital Management, LLC13G amended4.9%5.4M
29 Apr 2026Vanguard Capital Management13G5.25%5.8M
24 Apr 2026BlackRock, Inc.13G amended7.7%8.5M
26 Mar 2026The Vanguard Group13G amended0%0
14 Nov 2025Hotchkis and Wiley Capital Management, LLC13G amended7.74%8.9M
14 Nov 2025Rubric Capital Management LP13G9.09%10.4M

Short interest

Shares sold short and not yet bought back, on each FINRA settlement date.

SettlementShares shortChangeDays to cover
15 Oct 20266.3M+6.63%5.63
30 Sep 20265.9M+12.99%4.43
15 Sep 20265.3M+2.48%4.4
31 Aug 20265.1M+12.93%3.87
14 Aug 20264.5M+12.48%3.3
31 Jul 20264.0M-10.97%3.22
15 Jul 20264.5M+8.15%3.16
30 Jun 20264.2M+17.94%1.65

Funds that hold it

From each fund's latest Form 13F.

244 funds held it at 30 Jun 2026: 122 added and 54 trimmed in the quarter. The largest:

FundSharesValueChange in the quarter
BlackRock, Inc.10,666,032$132.8M+1,931,812
Rubric Capital Management LP8,211,888$102.2M-924,179
Dimensional Fund Advisors LP6,585,047$82.0M+86,393
Vanguard Portfolio Management LLC6,090,922$75.8M+846,516
FMR LLC5,333,701$66.4M+866,276
Arrowstreet Capital, Limited Partnership5,132,947$63.9M+303,913
Vanguard Capital Management LLC4,843,861$60.3M-133,719
Brown Advisory Inc.4,533,515$56.4M-308,659
American Century Companies Inc.3,474,853$43.3M+1,449,583
Geode Capital Management, LLC3,149,827$39.2M+386,373

Peers

Companies in the same industry.

  • Solstice Advanced Materials Inc. (SOLS): revenue $4.1B, market value $9.9B
  • Balchem Corp. (BCPC): revenue $1.1B, market value $5.4B
  • Perimeter Solutions, Inc. (PRM): revenue $757.1M, market value $4.7B
  • Ingevity Corp. (NGVT): revenue –, market value $2.6B
  • Innospec Inc. (IOSP): revenue $1.8B, market value $2.5B
  • Chemours Co. (CC): revenue $5.8B, market value $2.0B
  • Olin Corp. (OLN): revenue $6.7B, market value $1.8B
  • Huntsman Corp. (HUN): revenue $5.9B, market value $1.6B
  • FMC Corp. (FMC): revenue $3.3B, market value $598.6M
Manufacturing · NYSE companies · Every company we cover